| Product Code: ETC6738758 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cancer Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Cancer Therapeutics Market - Industry Life Cycle |
3.4 China Cancer Therapeutics Market - Porter's Five Forces |
3.5 China Cancer Therapeutics Market Revenues & Volume Share, By APPLICATION, 2021 & 2031F |
3.6 China Cancer Therapeutics Market Revenues & Volume Share, By TOP SELLING DRUGS, 2021 & 2031F |
4 China Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing adoption of innovative cancer therapies |
4.2.3 Government initiatives to improve cancer treatment and healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with cancer therapeutics |
4.3.2 Stringent regulatory requirements for drug approvals in China |
5 China Cancer Therapeutics Market Trends |
6 China Cancer Therapeutics Market, By Types |
6.1 China Cancer Therapeutics Market, By APPLICATION |
6.1.1 Overview and Analysis |
6.1.2 China Cancer Therapeutics Market Revenues & Volume, By APPLICATION, 2021- 2031F |
6.1.3 China Cancer Therapeutics Market Revenues & Volume, By Blood cancer, 2021- 2031F |
6.1.4 China Cancer Therapeutics Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.5 China Cancer Therapeutics Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.1.6 China Cancer Therapeutics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 China Cancer Therapeutics Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.1.8 China Cancer Therapeutics Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.1.9 China Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.1.10 China Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.2 China Cancer Therapeutics Market, By TOP SELLING DRUGS |
6.2.1 Overview and Analysis |
6.2.2 China Cancer Therapeutics Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.2.3 China Cancer Therapeutics Market Revenues & Volume, By Avastin, 2021- 2031F |
6.2.4 China Cancer Therapeutics Market Revenues & Volume, By Herceptin, 2021- 2031F |
6.2.5 China Cancer Therapeutics Market Revenues & Volume, By Rituxan, 2021- 2031F |
6.2.6 China Cancer Therapeutics Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.2.7 China Cancer Therapeutics Market Revenues & Volume, By Gleevec, 2021- 2031F |
6.2.8 China Cancer Therapeutics Market Revenues & Volume, By Imbruvica, 2021- 2031F |
6.2.9 China Cancer Therapeutics Market Revenues & Volume, By Imbruvica, 2021- 2031F |
7 China Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 China Cancer Therapeutics Market Export to Major Countries |
7.2 China Cancer Therapeutics Market Imports from Major Countries |
8 China Cancer Therapeutics Market Key Performance Indicators |
8.1 Average survival rate of cancer patients in China |
8.2 Number of clinical trials for cancer therapeutics in China |
8.3 Adoption rate of personalized medicine in cancer treatment in China |
9 China Cancer Therapeutics Market - Opportunity Assessment |
9.1 China Cancer Therapeutics Market Opportunity Assessment, By APPLICATION, 2021 & 2031F |
9.2 China Cancer Therapeutics Market Opportunity Assessment, By TOP SELLING DRUGS, 2021 & 2031F |
10 China Cancer Therapeutics Market - Competitive Landscape |
10.1 China Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here